Investigational Site Number : 6160010

Bydgoszcz, Kuyavian-Pomeranian Voivodeship 85-048

0 studies enrolling now · 2 studies all time

What they study most

Influenza Immunization

Studies at this site

• Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age. — Completed
• Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years — Stopped early